LSP BioVentures is a venture capital firmventure capital firm in Cambridge that prefers to invest in companies in the life science sector. Founded 2006 in Cambridge, Massachusetts, the firm invests in early stage ventures and late stage ventures. The notable investment portfolio of LSP BioVentures includes Imcyse, Lumeon, Aelin Therapeutics, Nouscom, Eloxx, Rainier Therapeutics, Immunic, Luxendo, Sequana Medical, and arGEN-X. As of January 2020, LSP BioVentures has made 14 investments and seven exits.

Edits on 16 Mar, 2020

Aime Anne Nisay

approved a suggestion from Golden's AI on 16 Mar, 2020

Edits made to:

Article (+15/-15 characters)

Article

LSP BioVentures is a venture capital firm in Cambridge that prefers to invest in companies in the life science sector. Founded 2006 in Cambridge, Massachusetts, the firm invests in early stage ventures and late stage ventures. The notable investment portfolio of LSP BioVentures includes Imcyse, Lumeon, Aelin Therapeutics, Nouscom, Eloxx, Rainier Therapeutics, Immunic, Luxendo, Sequana MedicalSequana Medical, and arGEN-X. As of January 2020, LSP BioVentures has made 14 investments and seven exits.

Edits on 12 Mar, 2020

Henry Ogolla

approved a suggestion from Golden's AI on 12 Mar, 2020

Edits made to:

Article (+7/-7 characters)

Article

LSP BioVentures is a venture capital firm in Cambridge that prefers to invest in companies in the life science sector. Founded 2006 in Cambridge, Massachusetts, the firm invests in early stage ventures and late stage ventures. The notable investment portfolio of LSP BioVentures includes Imcyse, Lumeon, Aelin Therapeutics, Nouscom, Eloxx, Rainier Therapeutics, Immunic, LuxendoLuxendo, Sequana Medical, and arGEN-X. As of January 2020, LSP BioVentures has made 14 investments and seven exits.

Neelam Jhaveri

approved a suggestion from Golden's AI on 12 Mar, 2020

Edits made to:

Article (+6/-6 characters)

Article

LSP BioVentures is a venture capital firm in Cambridge that prefers to invest in companies in the life science sector. Founded 2006 in Cambridge, Massachusetts, the firm invests in early stage ventures and late stage ventures. The notable investment portfolio of LSP BioVentures includes Imcyse, LumeonLumeon, Aelin Therapeutics, Nouscom, Eloxx, Rainier Therapeutics, Immunic, Luxendo, Sequana Medical, and arGEN-X. As of January 2020, LSP BioVentures has made 14 investments and seven exits.

Edits on 6 Mar, 2020

Aime Anne Nisay

approved a suggestion from Golden's AI on 6 Mar, 2020

Edits made to:

Article (+24/-24 characters)

Article

LSP BioVentures is a venture capital firm in Cambridge that prefers to invest in companies in the life science sector. Founded 2006 in Cambridge, MassachusettsCambridge, Massachusetts, the firm invests in early stage ventures and late stage ventures. The notable investment portfolio of LSP BioVentures includes Imcyse, Lumeon, Aelin Therapeutics, Nouscom, Eloxx, Rainier Therapeutics, Immunic, Luxendo, Sequana Medical, and arGEN-X. As of January 2020, LSP BioVentures has made 14 investments and seven exits.

Edits on 23 Jan, 2020

Marie G Bedia

edited on 23 Jan, 2020

Edits made to:

Description (+95 characters)

Article (+487 characters)

‌

LSP BioVentures

A Cambridge-based venture capital firm that invests in companies within the life science sector

Article

LSP BioVentures is a venture capital firm in Cambridge that prefers to invest in companies in the life science sector. Founded 2006 in Cambridge, Massachusetts, the firm invests in early stage ventures and late stage ventures. The notable investment portfolio of LSP BioVentures includes Imcyse, Lumeon, Aelin Therapeutics, Nouscom, Eloxx, Rainier Therapeutics, Immunic, Luxendo, Sequana Medical, and arGEN-X. As of January 2020, LSP BioVentures has made 14 investments and seven exits.

Find more companies like LSP BioVentures

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API